USD 16.88 billion
Transarterial Chemoembolization Market Size, Share, Growth Analysis, By Product(Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By End-User(Strawberry, apple, mango, mixed fruit blends), By Technology(Lipiodol-based TACE, Drug-Eluting Bead TACE Technology), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2318 |
Region:
Global |
Published Date: July, 2027
Pages:
219
|Tables:
92
|Figures:
76
Transarterial Chemoembolization Market Insights
Transarterial Chemoembolization Market size was valued at USD 17.81 Billion in 2023 and is poised to grow from USD 18.79 Billion in 2024 to USD 28.83 Billion by 2032, growing at a CAGR of 5.5% during the forecast period (2025-2032).
The global transarterial chemoembolization market has witnessed changes in consumers’ preferences and demands recently due to its minimally invasive treatment of hepatoma.
Demand for TACE continues increasing worldwide since the prevalence of liver cancer globally is increasing. The increase in liver cancer is mainly caused by risk factors e.g., hepatitis infections, alcohol consumption, and non-alcoholic fatty liver disease among others.
With the rapid innovations in medical technology, more elaborated and precise types of transarterial chemoembolization (TACE) are on the market nowadays. Adapted imaging procedures, emboli, and drug transportation devices have made TACE more accurate and cost-efficient, fueling industry growth.
Increased awareness of symptoms of liver cancer and how important it is for early diagnosis has led more patients to seek health care services in the initial stages. This is why TACE may be prescribed to patients with intermediate-grade liver cancer and thus support industry growth.
However, the market landscape could differ between regions due to issues like health care infrastructure, incidence rate of risk factors as well as regulatory set-ups. Particularly, Asia-Pacific have had huge developments, particularly because of higher liver cancer levels in some countries such as China.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
DEB-TACE
Fastest Growth
Microcatheters
Growth Rate
5.5% CAGR
Vertigo Treatment Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Transarterial Chemoembolization Market Segmental Analysis
The global transarterial chemoembolization market is segmented into four major segments i.e. by end-user, product type, technology, and region. Based on end-user, it is divided into hospitals, ambulatory surgical centers, specialty clinics. Based on product type, it is bifurcated as catheters, guidewires, microcatheters, embolic agents, chemotherapeutic agents. Based on technology it is segregated into, lipiodol-based TACE, drug-eluting bead TACE technology. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
Analysis by Type
The development and evaluation of DEB-TACE have received a lot of interest because it is an alternative administration method for controlled release of therapeutic drugs specifically to the tumor site. Using such a selective treatment as in the case of TACE may be associated with more favorable results than nonselective regimes and fewer systemic side effects. Administration of these therapies locally may limit systemic exposure and thereby toxicities in patients.
The success of TACE procedure is closely linked with microcatheters which are used for accurate traversing of the blood vessels to the target point.f # The emergence of more refined microcatheters with enhanced flexibility and maneuverability could further popularize their use. The emergence of modern, user-friendly, and mobile microcatheters would be a step in improving the accuracy of TACE procedures toward reaching tumor-feeding vessels.
Analysis by End-User
It is likely that hospitals will dominate the TACE end-user market. It is also common to find hospitals that are well equipped with state-of-the-art facilities like oncology and interventional radiology departments suitable for TACE procedures. Hospitalized patients receive TACE through the services of interventional radiologists and oncologists.
This implies that TACE procedures can experience faster growth among ASCs. ASCs are outpatient hospitals that concentrate on offering ambulatory surgeries that are often done in a day, and there is an increase in the growth of ambulatory care across different medical specialties. The performing of the TACE procedures in ASCs is usually less expensive compared to a hospital. Hence, due to the cost-conscious healthcare system, it may be driven by a shift.
Vertigo Treatment Market By End User
To get detailed analysis on other segments, Request For Free Sample Report
Transarterial Chemoembolization Market Regional Insights
There was a particular region with high demand in terms of the TACE market, called Asia-Pacific. Countries like China have a high prevalence rate of liver cancer. This trend goes along with increased education, better health facilities, as well as increased spending capacity, hence, making Asia Pacific dominate. The fact that some countries like China and India are investing in health care infrastructure and technology also supports the region’s capacity for TACE.
Faster expansion, which may pertain to the MENA (Middle East & Africa) region. Highlighting the growing attention to health infrastructure development, increased comprehension about cancer, and current sophistication in medicine gives potential for this region. Some Middle Eastern and African countries are making investments in their healthcare infrastructure, which could lead to enhanced access to modern treatments, like TACE.
Vertigo Treatment Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Transarterial Chemoembolization Market Dynamics
Drivers
Increasing Incidence of Liver Cancer Worldwide
- The increased incidence of liver cancer worldwide with demands for treatment such as the TACE. Moreover, the ongoing improvements in medical techniques continue to improve the accuracy and efficacy of such treatment processes, leading a doctor and a patient to choose them too. Minimally invasive procedures have also become vital drivers for TACE because it helps patients not experience the pain that comes with traditional treatment methods.
Restraints
High Complexity of Liver Cancer Cases
- The diversity of patients with liver cancer cases and their complexities as different treatment responses are a major market impediment in this case. The level of complexity associated with TACE may potentially restrict its universality and call for an individualized application strategy which ultimately might prevent wide implementation. Another challenge is coming from the stringent regulations in the country on the approval and reimbursement of medical procedures which serves as another restrain. Due to discrepancies in reimbursement strategies and protracted regulatory procedures, incorporating TACE into routine health care provision may be impeded.
Request Free Customization of this report to help us to meet your business objectives.
Transarterial Chemoembolization Market Competitive Landscape
Transarterial chemoembolization market is competitive, comprising both well-established vendors as well as new entrants that lead to dynamism in this industry. The major players in the market are engaging in strategies like new product development, collaboration, and consolidation to increase their dominance. Significant contributions to the competitive dynamics include established medical technology companies specializing in interventional oncology (development of advanced catheters, microcatheters, etc.) as well as embolic agents and drug-eluting bead technologies.
Top Player’s Company Profiles
- Boston Scientific Corporation (US)
- Terumo Corporation (Japan)
- Cook Medical (US)
- Cardinal Health (US)
- Becton, Dickinson and Company (US)
- Guerbet (France)
- AngioDynamics, Inc. (US)
- SIRtex Medical Inc. (Australia)
- Merit Medical Systems Inc. (US)
- Varian Medical Systems, Inc. (US)
- Microvena Therapeutics, Inc. (US)
- RadioMed LLC (US)
- IGT Laboratories (US)
- MicroCath, Inc. (US)
- Spectranetics, Inc. (US)
- Penumbra, Inc. (US)
- Oncotreat SA (Switzerland)
- Vascular Dynamics, Inc. (US)
- Shanghai Jahva Medical Co., Ltd. (China)
- Hangzhou Micro-Tech Co., Ltd. (China)
Recent Developments
- In May 2023 Bristol-Myers Squibb is evaluating nivolumab with ipilimumab and nivolumab alone in combination with trans-arterial chemotherapy-embolization (TACE) in participants with intermediate stage liver cancer (CheckMate 74W).
- In May 2023, Studies predicted that radiologic patterns play an important role in the outcome of early follow-up intra-arterial chemoembolization in individuals with intermediate-stage hepatocellular carcinoma.
- In March 2023, the correlation and effectiveness of Transarterial Chemoembolization (TACE) in mixture with lenvatinib and a PD-1 inhibitor are explored in the treatment of hepatocellular carcinoma (HCC) imparting with portal vein tumor thrombus.
Transarterial Chemoembolization Key Market Trends
Rising Emphasis on Personalized Medicine
- The trend towards the individualized treatment of liver cancer. The health care providers are exploring customised TACE based on patients’ characteristic and general health status including that of their tumour types. The trend supports the larger shift toward precision medicine to maximise the patient’s health outcome. Another major trend in the TACE market is technological innovations. This improves the performance of TACE which is ongoing research work to improve its preciseness and effectiveness. The latest developments in embolic agents, as well as, drug-eluting bead technologies and imaging technologies help target cancerous sites so that therapy can be effective with minimal negative impact to other tissues and body organs.
Transarterial Chemoembolization Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global trans-arterial chemo-embolization market presents a fluctuating arena that entails different patterns and challenges. This increases due to the increase in liver cancer rates, emerging technologies that improve accuracy, as well as patient preference towards minimally invasive surgeries. On the other hand, these cases are complicated, with many strict regulations, and the affordability challenge. Microcatheters are set for a great increase in popularity because of better targeting accuracy and drug-eluting beads TACE. Asia-Pacific a top contributor due to prevalent cases of liver cancer and the Middle East & Africa show strong potential. In summary, there are shifts towards personalised medicine, ever-emerging technologies and AI into the TACE process in general.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 17.81 Billion |
| Market size value in 2032 | USD 28.83 Billion |
| Growth Rate | 5.5% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Transarterial Chemoembolization Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Transarterial Chemoembolization Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Transarterial Chemoembolization Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Transarterial Chemoembolization Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Transarterial Chemoembolization Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Transarterial Chemoembolization Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
